Which is India’s first indigenously developed Receptor Binding Domain (RBD) protein sub-unit vaccine for COVID-19? [A] CORBEVAXTM [B] NOVAVAX [C] DIVIVAX [D] SEROVAXTM

user image

Abhishek Mishra

6 months ago

Answer: [A] CORBEVAXTM Notes: India’s first indigenously developed Receptor Binding Domain (RBD) protein sub-unit vaccine for COVID-19 is CORBEVAXTM. The vaccine, which has been developed by Biological E Limited, has recently received the Drug Controller General of India (DCGI) approval for Emergency Use Authorization (EUA). The Department of Biotechnology (DBT) and its PSU Biotechnology Industry Research Assistance Council (BIRAC), have supported Biological E’s COVID-19 vaccine candidate.

Recent Doubts

Close [x]